CBR Pharma Insights Market Research Reports





RSS Sort By :
TITLE Price Buy Now More options

Summary Pharmaceutical market is continuing to see global growth, whereas pharmaceutical and biotechnology companies are facing challenges due to disruptive events in the healthcare market such as increasing costs of produ...

$ 2995


Summary mHealth is often regarded as a branch of eHealth, which has been defined by the European Commission as “The use of modern information and communication technologies to meet needs of citizens, patients, health...

$ 2995


Summary Innovation is a crucial element of the pharmaceutical industry. The market is highly research-intensive, being deeply reliant on a high level of R&D investment and a strong product pipeline to maintain growth a...

$ 2995


Pharmaceutical lifecycle management (LCM) is the process of managing the entire lifecycle of a product including its research, design and manufacture, service and disposal. LCM is a well-established tool to maximize sales throughout the product li...

$ 2995


Summary Government support for biosimilars is increasing in key geographical markets, given the cost saving opportunities that these products represent for national healthcare budgets. A biosimilar is a bio-therapeutic tha...

$ 2995


Multichannel marketing (MCM) refers to the integration of various marketing channels into an overall synergetic strategy. Utilization of information from all the channels in a feedback loop is termed closed-loop marketing (CLM). While they require...

$ 2995


Data generation is growing at an exponential rate, so much so that 90% of the data in the world today was created in the last two years (IBM, 2016a). Big Data refers to any data set that is too large to store, process or analyze using traditional ...

$ 2995


Drug delivery technologies are engineered technologies that deliver drugs to achieve a therapeutic effect. Advances in these technologies usually aim to increase the efficacy of the drug, improve drug absorption and decrease side effects. The glob...

$ 2995


Private Equity is a term used to refer to money invested in private companies, and those companies become private through investment. However, in the financial industry the term is used to refer to firms that buy companies through leveraged buyout...

$ 2995


Generic drugs are identical or bioequivalent to branded drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. Although generic drugs are chemically identical to their branded counte...

$ 2995


GBI Research’s latest report, ""Stem Cell Therapies Global Trends in the Competitive, Technological and R&D Landscape"" provides an in-depth assessment of the current trends in the global stem cell therapy sector with...

$ 2995


GBI Research’s latest report, ""Innovation Tracking Factbook 2016An Assessment of the Pharmaceutical Pipeline"" is a comprehensive, granular analysis of the 20,756 products currently in the pharmaceutical industry pipelin...

$ 2995


GBI Research's latest report, ""Human Drugs For Veterinary Use Current Trends and Future Commercial Prospects for Crossover Drugs"", discusses global commercial trends and prospects for human medicines applied in the veteri...

$ 2995


GBI Research's latest report, "Substance Abuse Deterrents and Treatments An Assessment of the Technological, Competitive and R&D Landscape", discusses global trends in the substance abuse deterrents and addiction treatments marke...

$ 2995


GBI Research's latest report, ""Telehealth: Global Market Trends, Regulatory Landscape and Operational Strategies"", provides key insights into the global telehealth regulatory and market landscape, as well as its main appl...

$ 2995


SummaryGBI Research's latest report, "Evolving Market Access Strategies - Pricing and Reimbursement Landscape in Major Developed Pharmaceutical Markets" assesses developments within the key el...

$ 2995


GBI Research’s latest report, ""The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects"" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching dru...

$ 2995


GBI Research’s latest report, ""Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future"" discusses fundamental concepts in biobanking and recent technology advancements in the fie...

$ 2995


GBI Research’s latest report, ""Pharmaceutical Deal Trends (2010–2015) and In-Depth Analysis of Recent Deal Activity"" discusses deal-making trends for a range of deal types, such as Mergers & Acquisitions (M&am...

$ 2995


GBI Research’s latest report, "Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook" discusses all gene therapies under the broad criteria of genetic material introduced to the cell for a therapeutic p...

$ 2995


GBI Research’s latest report, ""Opioids Overview to 2021 - An Assessment of Pain Management and Dependence"" discusses the use of opioids as potent analgesics for the treatment of cancer and non-cancer pain and examines t...

$ 2995

Live Chat Support
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest from CBR Pharma Insights. We have market research reports of all sectors covered by the CBR Pharma Insights; you can access and utilize them at economical budgets.

More about our Subscription option